F1ANNEX IIILIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES USED IN VETERINARY MEDICINAL PRODUCTS FOR WHICH PROVISIONAL MAXIMUM RESIDUE LIMITS HAVE BEEN FIXED
Annotations:
Amendments (Textual)
F15.Anti-inflammatory agents
F15.1.Nonsteroidal anti-inflammatory agents
F15.1.1.Arylpropionic acid derivative
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F15.1.2.Enolic acid derivates
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F15.1.3.Pyrazolone derivatives
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F15.1.4.Sulfonated phenyl lactones
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Repealed by Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council (Text with EEA relevance).